Portfolio concentration
As of April 30, 2026 · N-PORT
Holdings
125
Top-10 weight
16.76%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
103
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
185.5
Holdings
As of April 30, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | DREYFUS GOVT CASH MGMT FUND | DGCXX | 852,188 | $852.19K | 2.28% |
| 2 | ERASCA INC | — | 76,668 | $816.51K | 2.19% |
| 3 | ENLIVEN THERAPEUTICS INC | — | 16,370 | $674.94K | 1.81% |
| 4 | TANGO THERAPEUTICS INC | — | 29,518 | $638.18K | 1.71% |
| 5 | ORUKA THERAPEUTICS INC | — | 9,143 | $625.47K | 1.68% |
| 6 | SPYRE THERAPEUTICS INC | — | 8,208 | $611.09K | 1.64% |
| 7 | ALUMIS INC | — | 24,020 | $593.05K | 1.59% |
| 8 | DIANTHUS THERAPEUTICS INC | — | 6,551 | $575.18K | 1.54% |
| 9 | KODIAK SCIENCES INC | — | 11,591 | $503.98K | 1.35% |
| 10 | REVOLUTION MEDICINES INC | — | 3,496 | $503.84K | 1.35% |
| 11 | CORVUS PHARMACEUTICALS INC | — | 32,976 | $500.91K | 1.34% |
| 12 | REZOLUTE INC | — | 153,338 | $490.68K | 1.31% |
| 13 | DEFINIUM THERAPEUTICS INC | — | 21,993 | $481.21K | 1.29% |
| 14 | CG ONCOLOGY INC | — | 6,741 | $449.89K | 1.21% |
| 15 | JADE BIOSCIENCES INC | — | 18,425 | $449.57K | 1.20% |
| 16 | INHIBRX BIOSCIENCES INC | — | 3,467 | $447.97K | 1.20% |
| 17 | RELAY THERAPEUTICS INC | — | 34,371 | $445.45K | 1.19% |
| 18 | GH RESEARCH PLC | GHRS | 21,175 | $434.72K | 1.16% |
| 19 | NEKTAR THERAPEUTICS | — | 5,045 | $429.03K | 1.15% |
| 20 | TYRA BIOSCIENCES INC | — | 12,196 | $423.81K | 1.14% |
| 21 | VIR BIOTECHNOLOGY INC | — | 41,256 | $421.43K | 1.13% |
| 22 | INTELLIA THERAPEUTICS INC | — | 30,599 | $412.47K | 1.10% |
| 23 | CENTESSA PHARMACEUTICALS LTD ADR | — | 10,411 | $410.40K | 1.10% |
| 24 | ANAPTYSBIO INC | — | 6,139 | $403.52K | 1.08% |
| 25 | OMEROS CORP | — | 27,192 | $397.00K | 1.06% |
| 26 | TECTONIC THERAPEUTIC INC | — | 13,966 | $390.63K | 1.05% |
| 27 | ALLOGENE THERAPEUTICS INC | — | 182,788 | $389.34K | 1.04% |
| 28 | COMPASS Pathways PLC, ADR | CMPS | 40,950 | $371.01K | 0.99% |
| 29 | EDGEWISE THERAPEUTICS INC | — | 11,685 | $361.77K | 0.97% |
| 30 | PALVELLA THERAPEUTICS INC | — | 2,798 | $359.04K | 0.96% |
| 31 | CAPRICOR THERAPEUTICS INC | — | 10,606 | $356.15K | 0.95% |
| 32 | VAXCYTE INC | — | 6,201 | $354.95K | 0.95% |
| 33 | PHARVARIS NV | PHVS | 11,424 | $354.26K | 0.95% |
| 34 | ARRIVENT BIOPHARMA INC | — | 11,300 | $351.32K | 0.94% |
| 35 | XENON PHARMACEUTICALS INC | — | 6,264 | $351.03K | 0.94% |
| 36 | NEUROGENE INC | — | 13,193 | $344.21K | 0.92% |
| 37 | SUMMIT THERAPEUTICS INC | — | 15,708 | $337.09K | 0.90% |
| 38 | AMYLYX PHARMACEUTICALS INC | — | 21,068 | $337.09K | 0.90% |
| 39 | CELLDEX THERAPEUTICS INC | — | 10,032 | $329.85K | 0.88% |
| 40 | PRAXIS PRECISION MEDICINES INC | — | 1,026 | $327.12K | 0.88% |
| 41 | ARCUS BIOSCIENCES INC | — | 12,819 | $326.88K | 0.88% |
| 42 | ANNEXON INC | — | 55,535 | $325.99K | 0.87% |
| 43 | TERNS PHARMACEUTICALS INC | — | 6,132 | $324.57K | 0.87% |
| 44 | LIQUIDIA TECHNOLOGIES INC | — | 8,268 | $324.19K | 0.87% |
| 45 | MONTE ROSA THERAPEUTICS INC | — | 16,922 | $324.06K | 0.87% |
| 46 | IMMUNOME INC | — | 14,102 | $323.50K | 0.87% |
| 47 | BICARA THERAPEUTICS INC | — | 14,934 | $322.28K | 0.86% |
| 48 | CELCUITY INC | — | 2,621 | $318.06K | 0.85% |
| 49 | IRONWOOD PHARMA CL A (PEND) | — | 77,097 | $318.03K | 0.85% |
| 50 | AbCellera Biologics Inc COM | ABCL | 76,245 | $316.42K | 0.85% |
1 / 3
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.